Stanley Center for Psychiatric Research

The mission of the Stanley Center for Psychiatric Research at Broad Institute is to reduce the burden of serious mental illness through research. The increasingly successful discovery of genetic variants associated with disease is only the beginning. Our goal is not to end with a list of genes, but to contribute to new understandings of pathogenesis, the identification of biomarkers, and above all, new treatments.

To address these challenges, the Stanley Center has not divided itself into disease-specific silos. Rather we are organized into intellectually porous teams based on principal disciplinary areas of focus:

We also focus extensively on new methodologies and tool development to further our understanding of biological mechanisms of disease. We collaborate with research groups around the world to identify important patient populations, technologies, and scientific approaches that will significantly advance our research objectives and knowledge for the psychiatric research community.

Through research at the Broad Institute and partnerships with collaborators worldwide, scientists at the Stanley Center aim to develop diagnostics and treatments to help people with mental health conditions. Our research informs our understanding of the biology of psychiatric disorders, neurodevelopmental conditions, and neurodegenerative disorders including schizophrenia, bipolar disorder, autism spectrum disorders, ADHD, and Alzheimer’s.

Click here to read the Stanley Center's Commitment to Genomic Data Sharing